Metabolic subgroups and cardiometabolic multimorbidity in the UK Biobank

Anwar Mulugeta, Elina Hyppönen, Mika Ala-Korpela, Ville-Petteri Mäkinen
doi: https://doi.org/10.1101/2021.02.01.21250893

Article Information

doi 
https://doi.org/10.1101/2021.02.01.21250893
History 
  • February 3, 2021.
Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-ND 4.0 International license.

Author Information

  1. Anwar Mulugeta1,
  2. Elina Hyppönen1,
  3. Mika Ala-Korpela2,3,4 and
  4. Ville-Petteri Mäkinen1,5,*
  1. 1Australian Centre for Precision Health, Unit of Clinical and Health Sciences, University of South Australia, Adelaide, Australia
  2. 2Computational Medicine, Faculty of Medicine, University of Oulu and Biocenter Oulu, Oulu, Finland
  3. 3Center for Life Course Health Research, Faculty of Medicine, University of Oulu, Oulu, Finland
  4. 4NMR Metabolomics Laboratory, School of Pharmacy, University of Eastern Finland, Kuopio, Finland
  5. 5Computational and Systems Biology Program, Precision Medicine Theme, South Australian Health and Medical Research Institute, Adelaide, Australia
  1. ↵*Corresponding author: Ville-Petteri Mäkinen, ville-petteri.makinen{at}sahmri.com
Back to top
Posted February 03, 2021.
Download PDF

Supplementary Material

Data/Code
Email
Metabolic subgroups and cardiometabolic multimorbidity in the UK Biobank
Anwar Mulugeta, Elina Hyppönen, Mika Ala-Korpela, Ville-Petteri Mäkinen
medRxiv 2021.02.01.21250893; doi: https://doi.org/10.1101/2021.02.01.21250893
Digg logo Reddit logo Twitter logo Facebook logo Google logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area